272 related articles for article (PubMed ID: 26891703)
1. Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma.
Grossberg AJ; Chamchod S; Fuller CD; Mohamed AS; Heukelom J; Eichelberger H; Kantor ME; Hutcheson KA; Gunn GB; Garden AS; Frank S; Phan J; Beadle B; Skinner HD; Morrison WH; Rosenthal DI
JAMA Oncol; 2016 Jun; 2(6):782-9. PubMed ID: 26891703
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment subcutaneous adipose tissue predicts the outcomes of patients with head and neck cancer receiving definitive radiation and chemoradiation in Taiwan.
Pai PC; Chuang CC; Chuang WC; Tsang NM; Tseng CK; Chen KH; Yen TC; Lin CY; Chang KP; Lei KF
Cancer Med; 2018 May; 7(5):1630-1641. PubMed ID: 29608254
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
Jung AR; Roh JL; Kim JS; Kim SB; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2019 Jul; 116():98-106. PubMed ID: 31185387
[TBL] [Abstract][Full Text] [Related]
4. Combined modality treatment outcomes for head and neck cancer: comparison of postoperative radiation therapy at academic vs nonacademic medical centers.
George JR; Yom SS; Wang SJ
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1118-26. PubMed ID: 24051518
[TBL] [Abstract][Full Text] [Related]
5. Progressive resistance training rebuilds lean body mass in head and neck cancer patients after radiotherapy--results from the randomized DAHANCA 25B trial.
Lønbro S; Dalgas U; Primdahl H; Johansen J; Nielsen JL; Aagaard P; Hermann AP; Overgaard J; Overgaard K
Radiother Oncol; 2013 Aug; 108(2):314-9. PubMed ID: 23932192
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
[TBL] [Abstract][Full Text] [Related]
7. An Intensive 18F-Fludeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Strategy of Follow-Up in Patients Treated for Head and Neck Squamous Cell Carcinoma Who Are Clinically Asymptomatic.
Leclère JC; Clément C; Le Pennec R; Maheo C; Gujral DM; Schick U; Le Gal G; Marianowski R; Salaun PY; Abgral R
JAMA Netw Open; 2023 Aug; 6(8):e2326654. PubMed ID: 37526935
[TBL] [Abstract][Full Text] [Related]
8. Discordance Between Oncology Clinician-Perceived and Radiologist-Intended Meaning of the Postradiotherapy Positron Emission Tomography/Computed Tomography Freeform Report for Head and Neck Cancer.
Patel Z; Schroeder JA; Bunch PM; Evans JK; Steber CR; Johnson AG; Farris JC; Hughes RT
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):927-934. PubMed ID: 35980655
[TBL] [Abstract][Full Text] [Related]
9. Association of Sarcopenia With Oncologic Outcomes of Primary Surgery or Definitive Radiotherapy Among Patients With Localized Oropharyngeal Squamous Cell Carcinoma.
Olson B; Edwards J; Stone L; Jiang A; Zhu X; Holland J; Li R; Andersen P; Krasnow S; Marks DL; Clayburgh D
JAMA Otolaryngol Head Neck Surg; 2020 Aug; 146(8):714-722. PubMed ID: 32525518
[TBL] [Abstract][Full Text] [Related]
10. Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224).
Saksø M; Mortensen LS; Primdahl H; Johansen J; Kallehauge J; Hansen CR; Overgaard J
Radiother Oncol; 2020 Oct; 151():126-133. PubMed ID: 32805273
[TBL] [Abstract][Full Text] [Related]
11. Weight loss and body mass index in relation to aspiration in patients treated for head and neck cancer: a long-term follow-up.
Ottosson S; Lindblom U; Wahlberg P; Nilsson P; Kjellén E; Zackrisson B; Levring Jäghagen E; Laurell G
Support Care Cancer; 2014 Sep; 22(9):2361-9. PubMed ID: 24687537
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
[TBL] [Abstract][Full Text] [Related]
13. Thoracic skeletal muscle index is effective for CT-defined sarcopenia evaluation in patients with head and neck cancer.
Vangelov B; Smee R; Moses D; Bauer J
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5583-5594. PubMed ID: 37573279
[TBL] [Abstract][Full Text] [Related]
14. Impact of obesity on outcomes for patients with head and neck cancer.
Hicks DF; Bakst R; Doucette J; Kann BH; Miles B; Genden E; Misiukiewicz K; Posner M; Gupta V
Oral Oncol; 2018 Aug; 83():11-17. PubMed ID: 30098765
[TBL] [Abstract][Full Text] [Related]
15. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
[TBL] [Abstract][Full Text] [Related]
17. Prediction of critical weight loss during radiation treatment in head and neck cancer patients is dependent on BMI.
Lønbro S; Petersen GB; Andersen JR; Johansen J
Support Care Cancer; 2016 May; 24(5):2101-2109. PubMed ID: 26553031
[TBL] [Abstract][Full Text] [Related]
18. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
Findlay M; White K; Brown C; Bauer JD
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy.
Rühle A; Marschner S; Haderlein M; Fabian A; Weymann M; Behrens M; Senger C; Dickstein DR; Kraft J; von der Grün J; Chen E; Aquino-Michaels T; Domschikowski J; Bickel A; Altay-Langguth A; Kalinauskaite G; Lewitzki V; Ferentinos K; Zamboglou C; Schnellhardt S; Haehl E; Spohn SKB; Gkika E; Zöller D; Guckenberger M; Budach V; Belka C; Bakst R; Mayer A; Schmidberger H; Grosu AL; Balermpas P; Stromberger C; Nicolay NH
JAMA Netw Open; 2023 Feb; 6(2):e230090. PubMed ID: 36808242
[TBL] [Abstract][Full Text] [Related]
20. Toxicity and outcomes in combined modality treatment of head and neck squamous cell carcinoma: cisplatin versus cetuximab.
Ye AY; Hay JH; Laskin JJ; Wu JS; Ho CC
J Cancer Res Ther; 2013; 9(4):607-12. PubMed ID: 24518704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
